• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TRIM47 在结直肠癌中上调,促进 SMAD4 的泛素化和降解。

TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.

机构信息

Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, 200001, China.

出版信息

J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.

DOI:10.1186/s13046-019-1143-x
PMID:30979374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6461818/
Abstract

BACKGROUND

Tripartite motif 47 (TRIM47), a member of the TRIM family proteins, plays a key role in many types of cancers including colorectal cancer (CRC). We found that levels of TRIM47 mRNA and protein were increased significantly in colorectal tumors compared with nontumor tissues and the increased levels were associated with advanced tumor stage and poor outcome.

METHODS

We used quantitative polymerase chain reaction and western blot to measure levels of TRIM47 mRNA and protein in human colorectal cancer and paired normal tissues. TRIM47 was knocked down and overexpressed in colorectal cancer cells, and the effects on cell proliferation, migration and growth of xenograft tumors in nude mice were assessed. The signaling pathways were examined by western blot and immunoprecipitation assays.

RESULTS

TRIM47 promoted CRC proliferation and metastasis in vitro and in vivo as an oncogene. Mechanistically, TRIM47 interacted physically with SMAD4, increasing its ubiquitination and degradation. Loss of SMAD4 leaded to up-regulation of CCL15 expression and caused growth and invasion in human CRC cells through the CCL15-CCR1 signaling. Moreover, TRIM47 overexpression played a role in CRC chemoresistance in response to 5-FU therapy.

CONCLUSIONS

Our study demonstrated a functional role of the TRIM47-SMAD4-CCL15 axis in CRC progression and suggested a potential target for CRC therapy.

摘要

背景

三结构域蛋白 47(TRIM47)是 TRIM 家族蛋白的成员,在包括结直肠癌(CRC)在内的多种癌症中发挥关键作用。我们发现,与非肿瘤组织相比,结直肠肿瘤中 TRIM47 mRNA 和蛋白水平显著升高,且升高水平与肿瘤晚期和预后不良相关。

方法

我们使用定量聚合酶链反应和 Western blot 检测了人结直肠癌和配对正常组织中 TRIM47 mRNA 和蛋白的水平。在结直肠癌细胞中敲低和过表达 TRIM47,并评估其对裸鼠异种移植肿瘤生长和转移的影响。通过 Western blot 和免疫沉淀实验检测信号通路。

结果

TRIM47 作为一种癌基因,在体外和体内促进 CRC 的增殖和转移。机制上,TRIM47 与 SMAD4 发生物理相互作用,增加其泛素化和降解。SMAD4 的缺失导致 CCL15 表达上调,并通过 CCL15-CCR1 信号通路导致人 CRC 细胞的生长和侵袭。此外,TRIM47 的过表达在 CRC 对 5-FU 治疗的化疗耐药中发挥作用。

结论

本研究证实了 TRIM47-SMAD4-CCL15 轴在 CRC 进展中的功能作用,并提示该轴可能成为 CRC 治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/89b24e36ce5a/13046_2019_1143_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/1d9fba70a2f4/13046_2019_1143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/e2b32c25efd7/13046_2019_1143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/2f9c9ad28c22/13046_2019_1143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/b2ea1269cd3a/13046_2019_1143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/bc9ef31f7fd6/13046_2019_1143_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/89b24e36ce5a/13046_2019_1143_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/1d9fba70a2f4/13046_2019_1143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/e2b32c25efd7/13046_2019_1143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/2f9c9ad28c22/13046_2019_1143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/b2ea1269cd3a/13046_2019_1143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/bc9ef31f7fd6/13046_2019_1143_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01ff/6461818/89b24e36ce5a/13046_2019_1143_Fig6_HTML.jpg

相似文献

1
TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.TRIM47 在结直肠癌中上调,促进 SMAD4 的泛素化和降解。
J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.
2
Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.结直肠癌细胞中 SMAD4 的缺失促进 CCL15 的表达,募集 CCR1+髓样细胞并促进肝转移。
Gastroenterology. 2013 Nov;145(5):1064-1075.e11. doi: 10.1053/j.gastro.2013.07.033. Epub 2013 Jul 25.
3
TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.TRIM47过表达是一个不良预后因素,并且在非小细胞肺癌的致癌过程中起作用。
Oncotarget. 2017 Apr 4;8(14):22730-22740. doi: 10.18632/oncotarget.15188.
4
Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.敲低 TRIM47 通过抑制 PI3K/Akt 通路抑制乳腺癌的发生发展。
Chem Biol Interact. 2020 Feb 1;317:108960. doi: 10.1016/j.cbi.2020.108960. Epub 2020 Jan 22.
5
Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer.三重基序(TRIM)47表达增加是人类前列腺癌的不良预后预测指标。
Clin Genitourin Cancer. 2016 Aug;14(4):298-303. doi: 10.1016/j.clgc.2016.01.011. Epub 2016 Jan 28.
6
Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.SMAD4 缺失通过 CCL15-CCR1 轴促进结直肠癌转移瘤相关中性粒细胞的积累,从而促进结直肠癌的肺转移。
Clin Cancer Res. 2017 Feb 1;23(3):833-844. doi: 10.1158/1078-0432.CCR-16-0520. Epub 2016 Aug 4.
7
Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.敲低TRIM47通过Wnt/β-连环蛋白信号通路失活抑制胶质瘤细胞增殖、迁移和侵袭。
Mol Cell Probes. 2020 Oct;53:101623. doi: 10.1016/j.mcp.2020.101623. Epub 2020 Jun 27.
8
TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.TRIM59 在胃癌肿瘤中上调,促进 p53 的泛素化和降解。
Gastroenterology. 2014 Nov;147(5):1043-54. doi: 10.1053/j.gastro.2014.07.021. Epub 2014 Jul 18.
9
TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination.TRIM47通过泛素化降解P53促进肾细胞癌的恶性进展。
Cancer Cell Int. 2021 Feb 23;21(1):129. doi: 10.1186/s12935-021-01831-0.
10
TRIM47 promotes glioma angiogenesis by suppressing Smad4.TRIM47 通过抑制 Smad4 促进胶质瘤血管生成。
In Vitro Cell Dev Biol Anim. 2022 Oct;58(9):771-779. doi: 10.1007/s11626-022-00722-6. Epub 2022 Oct 6.

引用本文的文献

1
TRIM47 Facilitates Osteosarcoma Progression via Destabilising FBP1 and Thus Activation of Wnt/β-Catenin Pathway.TRIM47通过使FBP1不稳定并由此激活Wnt/β-连环蛋白信号通路促进骨肉瘤进展。
J Cell Mol Med. 2025 Aug;29(15):e70753. doi: 10.1111/jcmm.70753.
2
Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination.三重基序蛋白47通过腺苷脱氨酶作用的RNA编辑酶(ADAR)泛素化促进甲状腺癌的发展。
Mol Med. 2025 Jul 5;31(1):252. doi: 10.1186/s10020-025-01298-z.
3
TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma.

本文引用的文献

1
Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer.白细胞介素 17 与适应性免疫在结直肠癌发病机制中的作用。
Gastroenterology. 2018 Dec;155(6):1706-1715. doi: 10.1053/j.gastro.2018.08.056. Epub 2018 Sep 13.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
TRIM6通过调节肺腺癌中的p53信号通路促进细胞周期和生长。
Int J Gen Med. 2025 Apr 13;18:2107-2117. doi: 10.2147/IJGM.S497383. eCollection 2025.
4
TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination.TRIM47 通过泛素化降解 XAF1 促进头颈部鳞状细胞癌的恶性进展。
iScience. 2024 Dec 13;28(1):111590. doi: 10.1016/j.isci.2024.111590. eCollection 2025 Jan 17.
5
Exploring the Mechanisms, Biomarkers, and Therapeutic Targets of TRIM Family in Gastrointestinal Cancer.探索TRIM家族在胃肠道癌中的作用机制、生物标志物及治疗靶点
Drug Des Devel Ther. 2024 Dec 5;18:5615-5639. doi: 10.2147/DDDT.S482340. eCollection 2024.
6
TRIM47 promotes hypopharyngeal and laryngeal cancers progression through promoting K63-linked ubiquitination of vimentin.TRIM47通过促进波形蛋白的K63连接泛素化来促进下咽癌和喉癌的进展。
Cancer Sci. 2025 Feb;116(2):367-380. doi: 10.1111/cas.16397. Epub 2024 Nov 25.
7
Arginine methylation-dependent TRIM47 stability mediated by CARM1 promotes the metastasis of hepatocellular carcinoma.由CARM1介导的精氨酸甲基化依赖性TRIM47稳定性促进肝细胞癌转移。
Cell Death Discov. 2024 Nov 20;10(1):477. doi: 10.1038/s41420-024-02244-4.
8
TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1.TRIM47是胆囊癌的一种预后生物标志物,通过调节PARP1的K63连接泛素化促进肿瘤进展。
Transl Oncol. 2025 Jan;51:102164. doi: 10.1016/j.tranon.2024.102164. Epub 2024 Nov 2.
9
TRIM47 promotes the Warburg effect and reduces ferroptosis in prostate cancer by FBP1 and FOXO1.TRIM47通过FBP1和FOXO1促进前列腺癌的瓦伯格效应并减少铁死亡。
Transl Androl Urol. 2024 Sep 30;13(9):1991-2004. doi: 10.21037/tau-23-605. Epub 2024 Sep 26.
10
Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity.膜联蛋白 A1 与 PDZ 和 LIM 结构域蛋白 7 结合抑制脂肪生成并预防肥胖。
Signal Transduct Target Ther. 2024 Aug 23;9(1):218. doi: 10.1038/s41392-024-01930-0.
TRIM65 通过促进 ANXA2 的泛素化和降解来支持膀胱尿路上皮癌细胞的侵袭性。
Cancer Lett. 2018 Oct 28;435:10-22. doi: 10.1016/j.canlet.2018.07.036. Epub 2018 Aug 1.
4
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.CCL15 招募抑制性单核细胞促进肝癌中的免疫逃逸和疾病进展。
Hepatology. 2019 Jan;69(1):143-159. doi: 10.1002/hep.30134. Epub 2018 Dec 31.
5
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity.在骨髓瘤细胞中进行的全基因组 CRISPR-Cas9 筛选鉴定了免疫调节药物敏感性的调节剂。
Leukemia. 2019 Jan;33(1):171-180. doi: 10.1038/s41375-018-0205-y. Epub 2018 Jul 19.
6
TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.TRIM27 通过激活结直肠癌细胞中的上皮-间充质转化和 p-AKT 发挥癌基因作用。
Int J Oncol. 2018 Aug;53(2):620-632. doi: 10.3892/ijo.2018.4408. Epub 2018 May 16.
7
TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.TRIM25 通过与 G3BP2 相互作用调节 p53 信号从而增强前列腺癌细胞的生长和存活。
Oncogene. 2018 Apr;37(16):2165-2180. doi: 10.1038/s41388-017-0095-x. Epub 2018 Jan 30.
8
Opposing roles of TGFβ and BMP signaling in prostate cancer development.转化生长因子β(TGFβ)和骨形态发生蛋白(BMP)信号在前列腺癌发展中的相反作用。
Genes Dev. 2017 Dec 1;31(23-24):2337-2342. doi: 10.1101/gad.307116.117.
9
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.去泛素化酶环指蛋白 41 减轻非酒精性脂肪性肝炎。
Nat Med. 2018 Feb;24(2):213-223. doi: 10.1038/nm.4461. Epub 2018 Jan 1.
10
Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases.三部分基序基因家族在结构和功能上的保守性表明,其在多种疾病的治疗中有应用潜力。
Pharmacol Ther. 2018 May;185:12-25. doi: 10.1016/j.pharmthera.2017.10.020. Epub 2017 Oct 31.